SEATTLE, March 01, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced that THC BioMed International Ltd. (CSE:THC) (CNSX:THC) (OTCQB:THCBF) has engaged CFN Media to conduct a 3-month investor and market visibility program to begin on March 1st, 2018.



“We’re excited to be working with THC BioMed, a licensed producer of medical cannabis in Canada and the country’s largest supplier of cannabis genetics,” said Frank Lane, President of CFN Media. “The company continues to expand its footprint, announcing in February, that it signed a letter of intent to purchase a farm in the Niagara region of Ontario with 70,000 sq. ft. in the greenhouses, as well as irrigation and other equipment that’s ready to grow medical marijuana.”

“Our recent DTC eligibility, GMP certification and moves to penetrate the International Cannabis Market necessitates the need to attract a wider Investor Audience. We look forward to working with CFN Media to develop our investor and market visibility while strengthening shareholder value,” commented John Miller, President and CEO of THC BioMed International.

CFN Media will leverage its powerful content platform and extensive reach into mainstream and cannabis-focused investor audiences and media across North America to attract high-quality investors to THC BioMed International Ltd. while elevating the company’s financial brand.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media

CFN Media (CannabisFN), the leading agency and financial media network dedicated to the worldwide cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Private and public marijuana companies in the US and Canada rely on CFN Media to succeed in the capital markets.

About THC BioMed International Ltd.

THC BioMed International Ltd. is an ACMPR Licensed Producer and Canada’s largest supplier of legal Cannabis Genetics. The company is on the leading edge of scientific research and the development of products and services related to the medical cannabis industry. Management believes THC is well positioned to be in the forefront of this rapidly growing industry.

Visit the company’s website at www.thcbiomed.com.

Frank Lane

206-369-7050

flane@cannabisfn.com